52 related articles for article (PubMed ID: 27148873)
1. Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells.
Jia L; Zhang S; Ye Y; Li X; Mercado-Uribe I; Bast RC; Liu J
Cancer Lett; 2012 Dec; 326(2):176-82. PubMed ID: 22902993
[TBL] [Abstract][Full Text] [Related]
2. Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells.
Lim YJ; Kim HS; Bae S; So KA; Kim TJ; Lee JH
Molecules; 2024 Jan; 29(1):. PubMed ID: 38202856
[TBL] [Abstract][Full Text] [Related]
3. Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies.
Labrie M; Li A; Creason A; Betts C; Keck J; Johnson B; Sivagnanam S; Boniface C; Ma H; Blucher A; Chang YH; Chin K; Vuky J; Guimaraes AR; Downey M; Lim JY; Gao L; Siex K; Parmar S; Kolodzie A; Spellman PT; Goecks J; Coussens LM; Corless CL; Bergan R; Gray JW; Mills GB; Mitri ZI
NPJ Precis Oncol; 2021 Oct; 5(1):92. PubMed ID: 34667258
[TBL] [Abstract][Full Text] [Related]
4. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
[TBL] [Abstract][Full Text] [Related]
5. Fucosterol Suppresses the Progression of Human Ovarian Cancer by Inducing Mitochondrial Dysfunction and Endoplasmic Reticulum Stress.
Bae H; Lee JY; Song G; Lim W
Mar Drugs; 2020 May; 18(5):. PubMed ID: 32429354
[TBL] [Abstract][Full Text] [Related]
6. Proteomics advances for precision therapy in ovarian cancer.
Labrie M; Kendsersky ND; Ma H; Campbell L; Eng J; Chin K; Mills GB
Expert Rev Proteomics; 2019 Oct; 16(10):841-850. PubMed ID: 31512530
[No Abstract] [Full Text] [Related]
7. Inhibition of Phospho-S6 Kinase, a Protein Involved in the Compensatory Adaptive Response, Increases the Efficacy of Paclitaxel in Reducing the Viability of Matrix-Attached Ovarian Cancer Cells.
Choi JI; Park SH; Lee HJ; Lee DW; Lee HN
PLoS One; 2016; 11(5):e0155052. PubMed ID: 27148873
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
Lee DW; Lee W; Kwon M; Lee HN
Oncol Rep; 2021 Jan; 45(1):390-400. PubMed ID: 33200225
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
10. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
Kim SH; Juhnn YS; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():82-9. PubMed ID: 17404021
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.
Halder J; Landen CN; Lutgendorf SK; Li Y; Jennings NB; Fan D; Nelkin GM; Schmandt R; Schaller MD; Sood AK
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8829-36. PubMed ID: 16361572
[TBL] [Abstract][Full Text] [Related]
12. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
